{"entity":{"type":"insider","cik":"0001881007","url":"/insider/0001881007","json_url":"/insider/0001881007.json","name":"Knight Jeff E.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2022-07-29","last":"2026-04-10","span_basis":"filed_date"},"name_variants":[{"name":"Knight Jeff E.","source":"filing","n_filings":8,"first_seen":"2022-07-29","last_seen":"2026-04-10"}],"transactions":[{"id":5746051,"accession":"0001628280-26-024716","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-26-024716","line_url":"/filing/0001628280-26-024716#line-4","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Dev. & Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Dev. & Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Dev. & Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85163.0,"shares_display":"85,163","price_per_share":40.1,"price_display":"40.10","price_state":"stated","total_value":3415036.3,"total_display":"3,415,036.30","total_whole":"3,415,036","shares_owned_after":105289.0,"shares_owned_after_display":"105,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-10","scope":"insider"},{"id":6059116,"accession":"0001628280-26-019503","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-019503","line_url":"/filing/0001628280-26-019503","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9911.0,"shares_display":"9,911","price_per_share":37.37377358490566,"price_display":"37.37","price_state":"stated","total_value":370411.47,"total_display":"370,411.47","total_whole":"370,411","shares_owned_after":115979.0,"shares_owned_after_display":"115,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-16","filed_date":"2026-03-18","scope":"insider","n_lines":2},{"id":5117573,"accession":"0000950170-25-043404","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-043404","line_url":"/filing/0000950170-25-043404","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7162.0,"shares_display":"7,162","price_per_share":34.203267243786655,"price_display":"34.20","price_state":"stated","total_value":244963.8,"total_display":"244,963.80","total_whole":"244,964","shares_owned_after":87852.0,"shares_owned_after_display":"87,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-19","filed_date":"2025-03-21","scope":"insider","n_lines":2},{"id":2749574,"accession":"0000950170-24-131064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-131064","line_url":"/filing/0000950170-24-131064#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":501.0,"shares_display":"501","price_per_share":56.52,"price_display":"56.52","price_state":"stated","total_value":28316.52,"total_display":"28,316.52","total_whole":"28,317","shares_owned_after":51653.0,"shares_owned_after_display":"51,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-22","filed_date":"2024-11-26","scope":"insider"},{"id":2142401,"accession":"0000950170-24-084346","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950170-24-084346","line_url":"/filing/0000950170-24-084346#line-4","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":55.0,"price_display":"55.00","price_state":"stated","total_value":1485000.0,"total_display":"1,485,000.00","total_whole":"1,485,000","shares_owned_after":51653.0,"shares_owned_after_display":"51,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-17","scope":"insider"},{"id":2589027,"accession":"0000950170-24-079152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-079152","line_url":"/filing/0000950170-24-079152#line-1","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":956.0,"shares_display":"956","price_per_share":44.38,"price_display":"44.38","price_state":"stated","total_value":42427.28,"total_display":"42,427.28","total_whole":"42,427","shares_owned_after":52580.0,"shares_owned_after_display":"52,580","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-28","scope":"insider"},{"id":2547534,"accession":"0001209191-24-005081","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-24-005081","line_url":"/filing/0001209191-24-005081","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32359.0,"shares_display":"32,359","price_per_share":44.305294044933405,"price_display":"44.31","price_state":"stated","total_value":1433675.01,"total_display":"1,433,675.01","total_whole":"1,433,675","shares_owned_after":54939.0,"shares_owned_after_display":"54,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-22","filed_date":"2024-03-26","scope":"insider","n_lines":2},{"id":6211628,"accession":"0001209191-22-043524","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-043524","line_url":"/filing/0001209191-22-043524#line-2","is_derivative":false,"issuer_cik":"0001658247","issuer_name":"Crinetics Pharmaceuticals, Inc.","issuer_ticker":"CRNX","issuer_name_source":null,"issuer_url":"/issuer/0001658247","owner_cik":"0001881007","owner_name":"Knight Jeff E.","owner_display_name":"Knight Jeff E.","owner_url":"/insider/0001881007","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1152.0,"shares_display":"1,152","price_per_share":20.7004,"price_display":"20.70","price_state":"stated","total_value":23846.8608,"total_display":"23,846.86","total_whole":"23,847","shares_owned_after":4950.0,"shares_owned_after_display":"4,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001658247","name":"Crinetics Pharmaceuticals, Inc.","url":"/issuer/0001658247","role":"Officer (Chief Dev. & Operating Officer)","n_filings":8,"first_seen":"2022-07-29","last_seen":"2026-04-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001881007","retrieved_at":"2026-08-24T18:26:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}